LJ

LI Jian

Vice President

CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited Pipeline

DrugIndicationPhase
Envafolimab (CIPTRAMON)MSI-H/dMMR solid tumorsApproved
DPP-1 Inhibitor (CSPC-2231)Acute exacerbation of COPD, BronchiectasisPhase III
IL-17A/F Inhibitor (CSPC-2232)PsoriasisPhase III
ADC Candidate (CSPC-5018)Advanced solid tumorsPhase I/II
Nectin-4 ADC (CSPC-5092)Advanced solid tumorsPhase I
TROP2 ADC (CSPC-6024)Advanced solid tumorsPhase I
Claudin 18.2 ADC (CSPC-5902)Advanced solid tumorsPhase I